Ronald S Jones1, Ulrike Auer2, Martina Mosing3. 1. School of Veterinary Science, University of Liverpool, Neston, UK. 2. Clinic of Anaesthesiology and Perioperative Intensive-Care Medicine, Veterinary University Vienna, Vienna, Austria. 3. Division of Anaesthesiology, Vetsuisse Faculty, University of Zürich, Zürich, Switzerland.
Abstract
OBJECTIVE: To review the evidence regarding the reversal of neuromuscular block (NMB) in companion animals with emphasis on the development and use of newer agents. DATABASE USED: Data sources include scientific reviews and original research publications in both human and veterinary literature using Pubmed and Scopus as search data bases. Unpublished and locally published data on reversal of NMB are presented. CONCLUSIONS: Residual NMB has been shown to increase morbidity and mortality in humans and needs to be avoided. It can be detected only by adequate neuromuscular monitoring. The proper use of reversal agents avoids residual NMB and recurarization should not occur. Anticholinesterase inhibitors, such as edrophonium and neostigmine have been used to reverse NMB when the need for this has been established. Reversal is influenced by several factors and a number of undesirable side- effects of these drugs have been reported. Sugammadex, a γ-cyclodextrin, which was designed specifically to encapsulate rocuronium, is more rapid in its actions, has fewer side effects and can reverse profound NMB induced by aminosteroidal muscle relaxants.
OBJECTIVE: To review the evidence regarding the reversal of neuromuscular block (NMB) in companion animals with emphasis on the development and use of newer agents. DATABASE USED: Data sources include scientific reviews and original research publications in both human and veterinary literature using Pubmed and Scopus as search data bases. Unpublished and locally published data on reversal of NMB are presented. CONCLUSIONS: Residual NMB has been shown to increase morbidity and mortality in humans and needs to be avoided. It can be detected only by adequate neuromuscular monitoring. The proper use of reversal agents avoids residual NMB and recurarization should not occur. Anticholinesterase inhibitors, such as edrophonium and neostigmine have been used to reverse NMB when the need for this has been established. Reversal is influenced by several factors and a number of undesirable side- effects of these drugs have been reported. Sugammadex, a γ-cyclodextrin, which was designed specifically to encapsulate rocuronium, is more rapid in its actions, has fewer side effects and can reverse profound NMB induced by aminosteroidal muscle relaxants.
Authors: Joaquin Araos; Pablo Cruces; Manuel Martin-Flores; Pablo Donati; Robin D Gleed; Tomas Boullhesen-Williams; Agustin Perez; Francesco Staffieri; Jaime Retamal; Marcos F Vidal Melo; Daniel E Hurtado Journal: Front Vet Sci Date: 2022-03-14
Authors: Caterina Di Bella; Caterina Vicenti; Joaquin Araos; Luca Lacitignola; Laura Fracassi; Marzia Stabile; Salvatore Grasso; Alberto Crovace; Francesco Staffieri Journal: Front Vet Sci Date: 2022-08-18